111 related articles for article (PubMed ID: 34932998)
1. Achievement and quality measure attainment in patients hospitalized with atrial fibrillation: Results from The Get With The Guidelines - Atrial Fibrillation (GWTG-AFIB) registry.
Ullal AJ; Holmes DN; Lytle BL; Matsouaka RA; Sheng S; Desai NR; Curtis AB; Fang MC; McCabe PJ; Fonarow GC; Russo AM; Lewis WR; Heidenreich PA; Piccini JP; Turakhia MP; Perino AC
Am Heart J; 2022 Mar; 245():90-99. PubMed ID: 34932998
[TBL] [Abstract][Full Text] [Related]
2. Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation: Findings From the Get With The Guidelines-Atrial Fibrillation Registry.
Essien UR; Chiswell K; Kaltenbach LA; Wang TY; Fonarow GC; Thomas KL; Turakhia MP; Benjamin EJ; Rodriguez F; Fang MC; Magnani JW; Yancy CW; Piccini JP
JAMA Cardiol; 2022 Dec; 7(12):1207-1217. PubMed ID: 36287545
[TBL] [Abstract][Full Text] [Related]
3. Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation Is Achievable.
Piccini JP; Xu H; Cox M; Matsouaka RA; Fonarow GC; Butler J; Curtis AB; Desai N; Fang M; McCabe PJ; Page Ii RL; Turakhia M; Russo AM; Knight BP; Sidhu M; Hurwitz JL; Ellenbogen KA; Lewis WR;
Circulation; 2019 Mar; 139(12):1497-1506. PubMed ID: 30700141
[TBL] [Abstract][Full Text] [Related]
4. Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.
Lewis WR; Piccini JP; Turakhia MP; Curtis AB; Fang M; Suter RE; Page RL; Fonarow GC
Circ Cardiovasc Qual Outcomes; 2014 Sep; 7(5):770-7. PubMed ID: 25185244
[TBL] [Abstract][Full Text] [Related]
5. Current Status and Time Trends of Oral Anticoagulation Use Among Chinese Patients With Nonvalvular Atrial Fibrillation: The Chinese Atrial Fibrillation Registry Study.
Chang SS; Dong JZ; Ma CS; Du X; Wu JH; Tang RB; Xia SJ; Guo XY; Yu RH; Long DY; Bai R; Liu N; Sang CH; Jiang CX; Liu XH; Pan JH; Lip GY
Stroke; 2016 Jul; 47(7):1803-10. PubMed ID: 27283198
[TBL] [Abstract][Full Text] [Related]
6. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
[TBL] [Abstract][Full Text] [Related]
7. Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program.
McIntyre WF; Conen D; Olshansky B; Halperin JL; Hayek E; Huisman MV; Lip GYH; Lu S; Healey JS
Clin Cardiol; 2018 Jun; 41(6):744-751. PubMed ID: 29546729
[TBL] [Abstract][Full Text] [Related]
8. Seasonal Variation of Atrial Fibrillation Admission and Quality of Care in the United States.
Sheehy S; Fonarow GC; Holmes DN; Lewis WR; Matsouaka RA; Piccini JP; Zhi L; Bhatt DL
J Am Heart Assoc; 2022 Feb; 11(4):e023110. PubMed ID: 35156386
[TBL] [Abstract][Full Text] [Related]
9. Underuse of oral anticoagulants in privately insured patients with atrial fibrillation: A population being targeted by the IMplementation of a randomized controlled trial to imProve treatment with oral AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AFib).
Al-Khatib SM; Pokorney SD; Al-Khalidi HR; Haynes K; Garcia C; Martin D; Goldsack JC; Harkins T; Cocoros NM; Lin ND; Lipowicz H; McCall D; Nair V; Parlett L; McMahill-Walraven CN; Platt R; Granger CB
Am Heart J; 2020 Nov; 229():110-117. PubMed ID: 32949986
[TBL] [Abstract][Full Text] [Related]
10. Use of Oral Anticoagulation in Eligible Patients Discharged With Heart Failure and Atrial Fibrillation.
Luo N; Xu H; Jneid H; Fonarow GC; Lopes RD; Piccini JP; Curtis AB; Russo AM; Lewis WR; Matsouaka RA; Granger CB; Mentz RJ; Al-Khatib SM
Circ Heart Fail; 2018 Oct; 11(10):e005356. PubMed ID: 30354398
[TBL] [Abstract][Full Text] [Related]
11. Oral Anticoagulant Therapy Prescription in Patients With Atrial Fibrillation Across the Spectrum of Stroke Risk: Insights From the NCDR PINNACLE Registry.
Hsu JC; Maddox TM; Kennedy KF; Katz DF; Marzec LN; Lubitz SA; Gehi AK; Turakhia MP; Marcus GM
JAMA Cardiol; 2016 Apr; 1(1):55-62. PubMed ID: 27437655
[TBL] [Abstract][Full Text] [Related]
12. Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
Cullen MW; Kim S; Piccini JP; Ansell JE; Fonarow GC; Hylek EM; Singer DE; Mahaffey KW; Kowey PR; Thomas L; Go AS; Lopes RD; Chang P; Peterson ED; Gersh BJ;
Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):461-9. PubMed ID: 23759473
[TBL] [Abstract][Full Text] [Related]
13. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry.
Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Oliveira MM; Mairesse G; Crijns HJ; Simantirakis E; Atar D; Kirchhof P; Vardas P; Tavazzi L; Maggioni AP
Europace; 2014 Mar; 16(3):308-19. PubMed ID: 24351881
[TBL] [Abstract][Full Text] [Related]
14. Underuse of anticoagulation in patients with atrial fibrillation.
Vallakati A; Lewis WR
Postgrad Med; 2016; 128(2):191-200. PubMed ID: 26666288
[TBL] [Abstract][Full Text] [Related]
15. Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation.
Perino AC; Fan J; Askari M; Heidenreich PA; Keung E; Raitt MH; Piccini JP; Ziegler PD; Turakhia MP
Circulation; 2019 May; 139(22):2502-2512. PubMed ID: 30880434
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
[TBL] [Abstract][Full Text] [Related]
17. Predictors of oral anticoagulant non-prescription in patients with atrial fibrillation and elevated stroke risk.
Lubitz SA; Khurshid S; Weng LC; Doros G; Keach JW; Gao Q; Gehi AK; Hsu JC; Reynolds MR; Turakhia MP; Maddox TM
Am Heart J; 2018 Jun; 200():24-31. PubMed ID: 29898845
[TBL] [Abstract][Full Text] [Related]
18. Stroke prevention, 1-year clinical outcomes and healthcare resource utilization in patients with atrial fibrillation in France: Data from the GARFIELD-AF registry.
Le Heuzey JY; Bassand JP; Berneau JB; Cozzolino P; D'Angiolella L; Doucet B; Mantovani LG; Martelet M; Mouallem J; Muller JJ; Pieper K;
Arch Cardiovasc Dis; 2018 Dec; 111(12):749-757. PubMed ID: 29861295
[TBL] [Abstract][Full Text] [Related]
19. Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort.
Shantsila E; Wolff A; Lip GY; Lane DA
Br J Gen Pract; 2015 Jan; 65(630):e16-23. PubMed ID: 25548312
[TBL] [Abstract][Full Text] [Related]
20. Use of Oral Anticoagulation in a Real-World Population With Device Detected Atrial Fibrillation.
Kaplan RM; Ziegler PD; Koehler J; Landman S; Sarkar S; Passman RS
J Am Heart Assoc; 2020 Dec; 9(24):e018378. PubMed ID: 33252286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
